Moderation of midlife cognitive activity on tau‐related cognitive impairment
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.14606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Kang Ko und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Cognitive Dysfunction, tau Proteins, Cognition. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science, ICT, and Future Planning, Republic of Korea, NIEHS NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
INTRODUCTION We investigated the moderating effects of midlife and late‐life cognitive activity (CA) on the relationship between tau pathology and both cognition and cognitive decline. METHODS Eighty‐nine non‐demented older adults from a Korean cohort underwent comprehensive evaluations, including CA assessments and tau neuroimaging at baseline, and Mini‐Mental State Examination (MMSE) at baseline and the 2‐year follow‐up. RESULTS Greater midlife CA was associated with higher MMSE scores in a given amount of tau pathology, whereas higher levels of midlife CA were associated with faster tau‐related decline in MMSE scores, particularly in individuals with mild cognitive impairment. Late‐life CA did not exhibit any interaction with tau on either MMSE scores or their 2‐year change. DISCUSSION Greater midlife CA is generally associated with better cognitive performance despite the presence of tau pathology. However, paradoxically, increased midlife CA appears to be linked to a more rapid tau‐related cognitive decline in already cognitively impaired individuals. Highlights Greater midlife cognitive activity (CA) was generally associated with better cognitive performance in a given amount of tau pathology. Paradoxically, higher levels of midlife CA were related to a more rapid tau‐related cognitive decline in already cognitively impaired individuals. Late‐life CA did not exhibit any moderation effect on the association between tau and cognitive performance or decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Psychiatry, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
- Institute of Human Behavioral Medicine, Medical Research Center, Seoul National University, Seoul, Republic of Korea.
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Psychiatry, Chungbuk National University Hospital, Cheongju, Republic of Korea.
- Department of Psychiatry, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.
ORCID-Profile: Kang Ko, Dahyun Yi, Min Soo Byun, Nayeong Kong, Gijung Jung, Yoon Young Chang, Musung Keum, Jun-Young Lee, Yun-Sang Lee, Yu Kyeong Kim, Dong Young Lee
Förderung
- Ministry of Science, ICT, and Future Planning, Republic of Korea
- NIEHS NIH HHS
- NIA NIH HHS
Zitieren
APA
Ko, K., Yi, D., Byun, M. S., Jung, J. H., Kong, N., Jung, G., Ahn, H., Chang, Y. Y., Keum, M., Lee, J. Y., Lee, Y. S., Kim, Y. K., Lee, D. Y., & KBASE Research Group (2025). Moderation of midlife cognitive activity on tau‐related cognitive impairment. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14606
Vancouver
Ko K, Yi D, Byun MS, Jung JH, Kong N, Jung G, et al. Moderation of midlife cognitive activity on tau‐related cognitive impairment. Alzheimer's & Dementia. 2025. doi:10.1002/alz.14606
BibTeX
@article{Ko2025,
author = {Ko, Kang and Yi, Dahyun and Byun, Min Soo and Jung, Joon Hyung and Kong, Nayeong and Jung, Gijung and Ahn, Hyejin and Chang, Yoon Young and Keum, Musung and Lee, Jun-Young and Lee, Yun-Sang and Kim, Yu Kyeong and Lee, Dong Young and KBASE Research Group, KBASE Research Group},
title = {Moderation of midlife cognitive activity on tau‐related cognitive impairment},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.14606}
}
EUVIMED